Gambia vs Sudan: Access to anti-retroviral drugs, male
Gambia
27.0%
in 2024
Sudan
23.0%
in 2024
Gambia rank
136th
Sudan rank
138th
Access to anti-retroviral drugs, male over time
- Gambia
- Sudan
How they compare
Gambia currently reports 27.0% against 23.0% in Sudan, a difference of 4.0%.
That makes Gambia's figure about 1.2 times Sudan's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Sudan ahead.
Gambia ranks 136th and Sudan ranks 138th of 141 countries.
Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 2.1% | 1.0% | Sudan |
| 2010s | 12.2% | 17.0% | 4.8% | Sudan |
| 2020s | 22.2% | 25.0% | 2.8% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Gambia or Sudan?
- Gambia, at 27.0% against 23.0% in Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Gambia and Sudan?
- 4.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Sudan?
- 22 years are reported by both, from 2000 to 2024.
- How do Gambia and Sudan rank globally for access to anti-retroviral drugs, male?
- Gambia ranks 136th and Sudan ranks 138th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.